- Home
- INSM vs STM Comparison
INSM vs STM Comparison
Compare INSM & STM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- STM
- Stock Information
- Founded
- INSM 1988
- STM 1987
- Country
- INSM United States
- STM Netherlands
- Employees
- INSM N/A
- STM N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- STM Semiconductors
- Sector
- INSM Health Care
- STM Technology
- Exchange
- INSM Nasdaq
- STM Nasdaq
- Market Cap
- INSM 29.0B
- STM 28.2B
- IPO Year
- INSM 2000
- STM 1994
- Fundamental
- Price
- INSM $189.60
- STM $24.47
- Analyst Decision
- INSM Strong Buy
- STM Buy
- Analyst Count
- INSM 19
- STM 8
- Target Price
- INSM $171.12
- STM $35.40
- AVG Volume (30 Days)
- INSM 2.1M
- STM 6.9M
- Earning Date
- INSM 10-30-2025
- STM 10-23-2025
- Dividend Yield
- INSM N/A
- STM 1.31%
- EPS Growth
- INSM N/A
- STM N/A
- EPS
- INSM N/A
- STM 0.58
- Revenue
- INSM $447,022,000.00
- STM $11,792,000,000.00
- Revenue This Year
- INSM $32.08
- STM N/A
- Revenue Next Year
- INSM $125.86
- STM $12.68
- P/E Ratio
- INSM N/A
- STM $40.84
- Revenue Growth
- INSM 30.34
- STM N/A
- 52 Week Low
- INSM $60.40
- STM $17.25
- 52 Week High
- INSM $197.08
- STM $33.47
- Technical
- Relative Strength Index (RSI)
- INSM 76.69
- STM 34.17
- Support Level
- INSM $154.79
- STM $24.63
- Resistance Level
- INSM $168.22
- STM $25.54
- Average True Range (ATR)
- INSM 6.44
- STM 0.70
- MACD
- INSM 1.81
- STM -0.53
- Stochastic Oscillator
- INSM 82.31
- STM 1.50
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.